Quick answer: Cognizant’s TriZetto business is enterprise payer software, consulting, and “touchless RCM” sold as a months-to-years SI motion. Waystar is a provider-side clearinghouse and payments platform with AltitudeAI. Pick Cognizant/TriZetto when you are already in a Cognizant or payer-admin relationship. Pick Waystar when you want a provider clearinghouse you can operate without a global SI program.
Inclusion criteria: Head-to-head on deployment model, EHR fit, payer coverage, and whether you must replace a clearinghouse or BPO.
Honest limitations: Substrate does not replace a clearinghouse, EHR, coder, or patient-billing platform. It automates post-submission AR. Claim status includes denial root-cause analysis (eligibility, records, medical necessity, wrong route), not just a 277 code or an 835 variance. Clinical edge cases still go to staff. Coding, CDI, and patient-facing billing are out of scope.
At a glance
Where Cognizant / TriZetto wins
- Payer administration and Facets-era estates that already run on Cognizant
- Touchless RCM programs bundled with consulting
- Buyers who want a global SI, not a mid-market clearinghouse swap
Where Waystar wins
- Provider-side 837/835 without a Cognizant program
- AltitudeAI and remits your billing team can operate
- Shorter commercial path for groups that are not buying SI
Also consider Substrate
Also consider Substrate when the gap is post-submission follow-up on the current PM: live in days, EDI and portal coverage across 3,500+ payers, PM writeback with a video audit trail, and denial root-cause analysis as part of claim status (eligibility, records, medical necessity, or wrong route) rather than a 277 code or an 835 variance alone. Substrate does not replace a clearinghouse, EHR, coder, or patient-billing platform. Cognizant is an SI. Waystar is a clearinghouse. The overlay sits on the current PM when unpaid claims still need a root cause after EDI.
Related alias page: TriZetto vs Availity.